SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

DOI Web Site Web Site 5 Citations

Journal

  • The Lancet

    The Lancet 396 (10262), 1595-1606, 2020-11

    Elsevier BV

Citations (5)*help

See more

Report a problem

Back to top